On January 6, 2021 Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, reported that James Oliviero, President and Chief Executive Officer, will participate in three virtual investor conferences in January 2021 (Press release, Checkpoint Therapeutics, JAN 6, 2021, View Source [SID1234573567]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the events are as follows:

10th Annual LifeSci Partners Corporate Access Event: The company will host virtual one-on-one meetings during the conference on Wednesday, January 6 through Friday, January 8 and Monday, January 11 through Thursday, January 14, 2021.
H.C. Wainwright Virtual BioConnect Conference: The company’s presentation will be available for on-demand viewing on Checkpoint’s website beginning Monday, January 11, 2021, at 6:00 a.m. EST.
B. Riley Securities’ Virtual Oncology Investor Conference: The company’s presentation will take place on Thursday, January 21, 2021, at 10 a.m. EST and will be available to all conference-registered institutional investors.
Webcasts of the H.C. Wainwright and B. Riley presentations will be available on the Events page, located within the Investors section of Checkpoint’s website, View Source, for approximately 30 days following each presentation.